I

Incyte

Biopharmaceutical company pursuing drug discovery.

Therapy Area Medical Lead Hematology - Associate Director

Biology & BiotechUpdated on Nov 10
Full-timeMunich, GermanyNo salary listed

About the Job

Requirements

  • An MD, PharmD, or PhD in life sciences; candidates with an MSc and substantial relevant experience will also be considered.
  • Extensive pharmaceutical industry experience and an established external network in hematology.
  • A track record of successful cross-functional pre-launch planning and launch execution in malignant hematology, myeloproliferative neoplasms, or hemostasis.
  • Experience as an Information Officer under §74a of the German Medicines Act.
  • Experience planning and implementing early access programs and compassionate use requests in rare diseases or hematology.
  • A strong understanding of the German treatment and reimbursement landscape, including the ability to identify relevant evidence gaps and translate them into medical priorities.
  • Excellent communication skills, including in complex discussions with regulatory authorities and in G-BA/AMNOG hearings.
  • Fluency in German and English.
  • Willingness to travel up to 25% of working time.
  • Proficiency in Microsoft Office applications.

Responsibilities

  • Translate developments in hematology, emerging evidence, and changes in treatment guidelines into priorities for the German medical plan.
  • Identify unmet needs, scientific questions, and evidence gaps relevant to clinical practice and reimbursement in Germany, and develop strategies to address them.
  • Contribute to the national development program, connecting local insight with the company’s broader development strategy.
  • Define medical pre-launch and launch strategies with the Executive Medical Director, aligning across Medical Affairs, Commercial, and Market Access.
  • Plan and manage resources within the annual Medical Affairs budget.
  • Build and deepen trusted relationships with hematologists, investigators, medical societies, and other key scientific stakeholders.
  • Lead medical and scientific exchanges with a strong understanding of the disease landscape.
  • Serve as a primary medical contact within the area of responsibility, including the initial assessment of investigator-initiated research proposals for scientific merit and strategic fit.
  • Support research collaborations and timely communication and publication of findings from national investigator-initiated projects.
  • Provide medical leadership and scientific expertise to Market Access dossiers.
  • Guide the development of accurate, balanced, evidence-based medical materials, educational programs, and scientific communications.
  • Shape advisory boards, educational symposia, investigator meetings, and the organization’s presence at medical congresses.
  • Deliver scientific presentations and support training for internal colleagues and external audiences.
  • Ensure medical activities meet applicable compliance, regulatory, and legal requirements, with patient interests and scientific integrity at the centre.

Desired Qualifications

  • Leadership experience and previous budget responsibility.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs